Depuy Synthes Ortho Message Board

Synthes App

5 years ago

You are so valuable that your own company has an app which is the first step in replacing you.

Intermountain Healthcare to let its doctors recommend medical marijuana

3 days ago

After the Utah Medical Cannabis Act passed in December, Intermountain Healthcare reached out to a number of people, including patients, advocates, physicians, nurses, and pharmacists in an effort to understand how to implement care for those patients with a qualifying condition as defined by the Utah Medical Cannabis Act.

Bam Bam, Pam Pam

4 years ago

They all weren't that well rehearsed.

  • A plaintiff's lawyer yesterday pushed the executive in charge of Johnson & Johnson's (NYSE:JNJ) global clinical research to admit that the medical device company failed to perform critical safety tests on the DePuy Pinnacle hip implant.

Another J&J exec pressed in lawsuit over Pinnacle hip implant

The plaintiff's lawyer in the 1st product liability trial over DePuy's Pinnacle hip replacement grills another Johnson & Johnson executive, worldwide clinical research vice president Pamela Plouhar, the at DePuy, over the metal-on-metal implants.

Medivis Launches AR Technology Platform for Surgical Applications

4 days ago

Medivis, a medical imaging and visualization company for surgical applications, has officially unveiled "SurgicalAR," its augmented reality (AR) technology platform for surgical applications that leverages Microsoft HoloLens technology to improve surgical precision and operator confidence while ensuring patient safety.

Zimmer Biomet

3 years ago

They're making some moves on our business. What to do?


3 years ago

Is she the undertaker?

Johnson & Johnson Earnings Presentation Q42015

3 years ago

It doesn't take a genius to see JNJ needs to sell the device business. It would probably be better for us in the long run. Get picked up by another company and they will right size each division but the ones who make the cut will probably be paid more than we are here.

All the major analysts are pushing for a sale of the entire division and I can't see a reason why Gorsky wouldn't do it. Pay me out on my pension, throw some baby shampoo in and get me the F out of here.

DePuke Blows

3 years ago

I stand by the Credo no matter what.

JNJ inks deal for bundled payments for hip & knee replacements

3 years ago

Reduced cost, add a middleman in the equation and that is less money for the sales rep.

JNJ doing what they do best: screwing their sales team.

Synthes Non-Compete

3 years ago

They can fire us whenever they want but we can't go work for a competitor even if we are let go. Unbelievable world we live in.